12tldr is a free AI article summarizer. Paste any article URL and get a structured summary with TL;DR bullet points, context, key details, and why it matters — all in seconds.

How does 12tldr work?

Paste an article URL into the input field and click Summarize. Our AI reads the article and generates a clear, structured summary. No signup or account is required.

Is 12tldr free to use?

Yes, 12tldr is completely free. No account, no subscription, no tracking required.

Which websites does 12tldr support?

12tldr works with articles from most major publications including The Economist, New York Times, Bloomberg, BBC, Reuters, The Guardian, Wired, and thousands of other websites.

What does the AI summary include?

Each summary includes a TL;DR with three bullet points, a 'What it's about' section, 'The details' with key facts, and 'Why it matters' — giving you a complete picture without reading the full article.

Michigan Boy First Kid to Get Lyfgenia Gene Therapy for Sickle Cell

Source: freep.com

12-year-old Jayden at Children's Hospital of Michigan is the first child nationwide to receive Lyfgenia, a groundbreaking gene therapy for sickle cell disease.
Jayden underwent intense chemo and stem cell transplant, now producing more healthy hemoglobin with no pain crises since treatment.
This one-time therapy from bluebird bio could free kids from lifelong sickle cell suffering, though long-term risks remain.

A young boy named Jayden became the first pediatric patient in the U.S. to get Lyfgenia, an FDA-approved gene therapy for sickle cell disease, at Children's Hospital of Michigan. The story follows his journey through the grueling treatment process and early signs of success. It highlights hope for the 100,000 Americans, mostly Black kids, battling this painful genetic blood disorder.